Rispenzepine
Alternative Names: DF 594; UlvenzepineLatest Information Update: 05 Sep 1997
Price :
$50 *
At a glance
- Originator Dompe
- Class Small molecules
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Bronchitis
Most Recent Events
- 05 Sep 1997 Discontinued-II for Asthma in Italy (Inhalation)
- 05 Sep 1997 Discontinued-II for Asthma in United Kingdom (Inhalation)
- 05 Sep 1997 Discontinued-II for Bronchitis in Italy (Inhalation)